Cargando…

Lowering apolipoprotein CIII protects against high-fat diet–induced metabolic derangements

Increased levels of apolipoprotein CIII (apoCIII), a key regulator of lipid metabolism, result in obesity-related metabolic derangements. We investigated mechanistically whether lowering or preventing high-fat diet (HFD)–induced increase in apoCIII protects against the detrimental metabolic conseque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valladolid-Acebes, Ismael, Åvall, Karin, Recio-López, Patricia, Moruzzi, Noah, Bryzgalova, Galyna, Björnholm, Marie, Krook, Anna, Alonso, Elena Fauste, Ericsson, Madelene, Landfors, Fredrik, Nilsson, Stefan K., Berggren, Per-Olof, Juntti-Berggren, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954448/ https://www.ncbi.nlm.nih.gov/pubmed/33712458 http://dx.doi.org/10.1126/sciadv.abc2931

Ejemplares similares

Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle
por: Valladolid-Acebes, Ismael, et al.
Publicado: (2021)

Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice
por: Recio-López, Patricia, et al.
Publicado: (2021)

Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
por: Åvall, Karin, et al.
Publicado: (2018)

Tissue‐specific expression of insulin receptor isoforms in obesity/type 2 diabetes mouse models
por: Moruzzi, Noah, et al.
Publicado: (2021)

Mitochondrial impairment and intracellular reactive oxygen species alter primary cilia morphology
por: Moruzzi, Noah, et al.
Publicado: (2022)

Diet-induced β-cell insulin resistance results in reversible loss of functional β-cell mass
por: Paschen, Meike, et al.
Publicado: (2019)

Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII
por: Olivieri, Oliviero, et al.
Publicado: (2019)

Non-invasive cell type selective in vivo monitoring of insulin resistance dynamics
por: Paschen, Meike, et al.
Publicado: (2016)

Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
por: Guan, Yunpeng, et al.
Publicado: (2021)

Meal-Related Changes in Apolipoprotein Particles After Treatment With an Antisense Oligonucleotide to Apolipoprotein CIII
por: Brite, Brianna, et al.
Publicado: (2021)

Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes
por: HU, ZHI-JUAN, et al.
Publicado: (2014)

Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men
por: Faghihnia, Nastaran, et al.
Publicado: (2012)

CD14(+)-Monocytes Exposed to Apolipoprotein CIII Express Tissue Factor
por: Olivieri, Oliviero, et al.
Publicado: (2023)

Drp1 Overexpression Decreases Insulin Content in Pancreatic MIN6 Cells
por: Kabra, Uma D., et al.
Publicado: (2022)

Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells
por: Sol, E-ri M, et al.
Publicado: (2009)

Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry
por: Demus, Daniel, et al.
Publicado: (2021)

Ectopic Leptin Production by Intraocular Pancreatic Islet Organoids Ameliorates the Metabolic Phenotype of ob/ob Mice
por: Leibiger, Barbara, et al.
Publicado: (2021)

Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion
por: Zheng, Chunyu, et al.
Publicado: (2013)

Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism
por: Luo, Mengdie, et al.
Publicado: (2018)

Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids
por: Naber, Annemieke, et al.
Publicado: (2023)

Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
por: Lee, Hui-Young, et al.
Publicado: (2011)

The relationship between apolipoprotein CIII gene polymorphism and serum lipid levels in Han Chinese males()
por: Su, Shu, et al.
Publicado: (2013)

Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
por: Taskinen, Marja-Riitta, et al.
Publicado: (2016)

Mass Spectrometry of Transferrin and Apolipoprotein CIII from Dried Blood Spots for Congenital Disorders of Glycosylation
por: Wada, Yoshinao, et al.
Publicado: (2022)

SstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province
por: Bandegi, Ahmad Reza, et al.
Publicado: (2011)

Association of serum lipids and coronary artery disease with polymorphisms in the apolipoprotein AI-CIII-AIV gene cluster
por: Rai, Himanshu, et al.
Publicado: (2016)

Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
por: Katzmann, Julius L., et al.
Publicado: (2020)

Volanesorsen, an Antisense Oligonucleotide to Apolipoprotein-CIII, Decreases Triglycerides and Increases Lipoprotein Lipase Activity in Partial Lipodystrophy
por: Lightbourne, Marissa, et al.
Publicado: (2021)

Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death
por: Paiva, Adriene A., et al.
Publicado: (2017)

A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening
por: Lee, Sang Jun, et al.
Publicado: (2017)

Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2013)

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2019)

Modelling of dysregulated glucagon secretion in type 2 diabetes by considering mitochondrial alterations in pancreatic α-cells
por: Grubelnik, Vladimir, et al.
Publicado: (2020)

Apolipoprotein CIII regulates lipoprotein-associated phospholipase A(2) expression via the MAPK and NFκB pathways
por: Han, Xiaolei, et al.
Publicado: (2015)

Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele
por: Olivieri, Oliviero, et al.
Publicado: (2013)

APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome
por: Fallaize, Rosalind, et al.
Publicado: (2017)

Electrospray Ionization Mass Spectrometry of Apolipoprotein CIII to Evaluate O-glycan Site Occupancy and Sialylation in Congenital Disorders of Glycosylation
por: Wada, Yoshinao, et al.
Publicado: (2022)

SNAP-25b-deficiency increases insulin secretion and changes spatiotemporal profile of Ca(2+)oscillations in β cell networks
por: Daraio, Teresa, et al.
Publicado: (2017)

aP2-Cre-Mediated Inactivation of Estrogen Receptor Alpha Causes Hydrometra
por: Antonson, Per, et al.
Publicado: (2014)

Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes
por: Mir-Coll, Joan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_olk8ncd7smpj9pnl6p26jht44a